Lisa Dwane et al. [36] identified USP11 as a novel transcriptional regulator of ERα in breast cancer through a functional genomic screen, and they found that USP11 could significantly inhibit the activity of ERα and the transcription of downstream target genes in response to estradiol stimulation. Here, USP11 is linked to breast carcinoma.